Publications by authors named "Dawn Goodall"

Claim this Profile
F
Frailty Impact on Kidney Transplantation in Older People.
Amarpreet K Thind, Michelle Willicombe, Frank J M F Dor, Lina Johansson, Nicola Thomas, Dawn Goodall

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation.
Sarah Gleeson, Paul Martin, Tina Thomson, Katrina J Spensley, Dawn Goodall

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of frailty and cognitive impairment in older transplant candidates - a preview to the Kidney Transplantation in Older People (KTOP): impact of frailty on outcomes study.
Amarpreet K Thind, Annabel Rule, Dawn Goodall, Shuli Levy, Sarah Brice

BMC Nephrol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant-Related Nephropathy in a Renal Transplant Recipient.
Hiranya D Tennekoon, Andreas Kousios, Rebecca Gardiner, Linda Moran, Dawn Goodall

Kidney Int Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Assessment of C4d-Positive Renal Transplant Biopsies Without Evidence of Rejection.
Katherine M Dominy, Michelle Willicombe, Tariq Al Johani, Hannah Beckwith, Dawn Goodall

Kidney Int Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation - a retrospective study.
Michelle Willicombe, Dawn Goodall, Adam G McLean, David Taube

Transpl Int· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients.
Dawn L Goodall, Michelle Willicombe, Adam G McLean, David Taube

Transplant Direct· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab induction therapy in HIV-positive renal transplant recipients.
Florence E Mclean, Esther Gathogo, Dawn Goodall, Rachael Jones, Sabine Kinloch

AIDS· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol.
Michelle Willicombe, Anna Rizzello, Dawn Goodall, Vassilios Papalois, Adam G McLean

World J Transplant· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and outcomes of stroke post-transplantation in patients receiving a steroid sparing immunosuppression protocol.
Michelle Willicombe, Nicola Kumar, Dawn Goodall, Candice Clarke, Adam G McLean

Clin Transplant· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial.
Kakit Chan, David Taube, Candice Roufosse, Terence Cook, Paul Brookes, Dawn Goodall

Transplantation· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis